The HIV testing algorithm
16 min
Skills you'll build3 skills
- Choose the next laboratory test in the HIV diagnostic algorithm
- Recognize when recent exposure or antiretroviral use limits HIV detection
- Choose virologic testing for an infant with possible perinatal HIV exposure
At the bench: Relate viral serology findings to the stage of infection
Try first
Get the idea
Use the explanation to check your first decision.
The three-step algorithm
Laboratory HIV testing of serum or plasma follows a set sequence. The laboratory reports each assay result with one combined interpretation.1
- Antigen/antibody screen. A fourth-generation assay detects HIV-1 p24 antigen with HIV-1 and HIV-2 antibody. A nonreactive result shows no laboratory evidence of HIV infection. A reactive result is repeated as the manufacturer directs and is presumptive.1,2
- Antibody differentiation. The HIV-1/HIV-2 differentiation immunoassay reports HIV-1 positive, HIV-2 positive or HIV positive untypable. An antibody-negative or indeterminate result goes to step 3.1
- Nucleic acid amplification test (NAAT). Detected HIV-1 RNA supports acute HIV-1 infection and is reported promptly to the provider and the health department. HIV-1 RNA not detected after an antibody-negative or HIV-1 indeterminate differentiation result is interpreted as HIV negative.1
Window periods
Each assay becomes reactive some days after infection. Before that, a nonreactive result cannot exclude infection.
| Test | Usual detection window after exposure |
|---|---|
| Laboratory antigen/antibody test on venous blood | 18 to 45 days |
| Fingerstick antigen/antibody rapid test | 18 to 90 days |
| Antibody-only test | 23 to 90 days |
| Nucleic acid test (NAT) | 10 to 33 days |
A nonreactive result after a recent exposure is followed by the full algorithm on a later specimen. A negative rapid test during a suspected recent exposure is repeated with laboratory testing.1,3 Antiretroviral drugs taken for treatment or pre-exposure prophylaxis (PrEP) can suppress viremia and delay antibody. For a person taking PrEP, CDC recommends a laboratory antigen/antibody test and an HIV RNA test at the same time.1
Infants need virologic tests
Maternal IgG crosses the placenta. Antibody and antigen/antibody tests therefore cannot diagnose HIV in an infant younger than 18 months.4 An exposed infant has HIV RNA or DNA tests at birth, at 14 to 21 days, at 1 to 2 months and at 4 to 6 months. A positive virologic test is confirmed on a second specimen as soon as possible. Cord blood is never used.4
Follow the bench demonstration
Sources for this step
References
- Association of Public Health Laboratories. Suggested Reporting Language for the HIV Laboratory Diagnostic Testing Algorithm. 4th ed. October 2025. Accessed September 27, 2026. https://aphl.org/docs/default-source/technical/id-hiv-suggested-reporting-language.pdf
- Centers for Disease Control and Prevention and Association of Public Health Laboratories. Laboratory Testing for the Diagnosis of HIV Infection: Updated Recommendations. June 27, 2014. doi:10.15620/cdc.23447
- Centers for Disease Control and Prevention. HIV testing. Updated August 17, 2026. Accessed September 27, 2026. https://www.cdc.gov/hivpartners/php/hiv-testing/index.html
- Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Updated June 25, 2026. Accessed September 27, 2026. https://clinicalinfo.hiv.gov/en/guidelines/perinatal/management-infants-diagnosis-hiv-infection-children
Watch one
Read each decision and its explanation.
A 41-year-old woman has a routine HIV screen. She reports no recent exposure. Her results:
What is the algorithm's interpretation?
| Test | Result | Reference interval | Flag |
|---|---|---|---|
| HIV-1/HIV-2 antigen/antibody screen | Reactive, repeated in duplicate | NonreactiveNonreactive | |
| HIV-1/HIV-2 antibody differentiation | HIV-1 Indeterminate | ||
| HIV-1 RNA, qualitative NAAT | Not detected | Not detectedNot detected |
Specimen: H 4, L 10, I 1. Plasma, EDTA
- The screen was reactive initially and on repeat, so the specimen went on to step 2.
A repeatedly reactive screen is what sends a specimen on to supplemental testing.
- The differentiation assay result is HIV-1 Indeterminate, so the specimen goes to NAAT.
An indeterminate differentiation result cannot confirm or exclude antibody, so it goes to step 3.
- HIV-1 RNA is not detected.
The indeterminate result is for HIV-1, so an HIV-1 NAAT resolves it.
- An HIV-1 Indeterminate result with HIV-1 RNA not detected is interpreted as HIV negative.
The algorithm defines this combination.
- Report each assay result together with the interpretation. If recent exposure is later suspected, request a new specimen and repeat the algorithm.
The provider needs every assay result that led to the interpretation.
Your turn
Use it
Read the case evidence, then make each decision. The step is complete without it.
- Tomas Triplett, 23, had a condomless sexual exposure 24 days ago. He takes no antiretroviral drugs.
- A fingerstick rapid antibody test at a community clinic was nonreactive 2 days ago.
- The clinic then sent venous plasma to your laboratory.
| Test | Result | Reference interval | Flag |
|---|---|---|---|
| HIV-1/HIV-2 antigen/antibody screen | Reactive, repeated in duplicate | NonreactiveNonreactive | |
| HIV-1/HIV-2 antibody differentiation | HIV antibody negative |
Specimen: H 3, L 9, I 1. Plasma, EDTA, collected 24 days after exposure
The exposure 24 days before collection explains the results. At that point the rapid antibody test can be nonreactive and the laboratory screen can detect p24 antigen before antibody appears. NAAT completes the algorithm.
Review missed questions
For reference
Sources checked